Dapasmart
Dapasmart

3.75
Used to address diabetes, this generic medicine promotes the renal excretion of glucose. Lowers blood glucose levels by preventing glucose reabsorption in the kidneys.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dapagliflozin
Reference Brand
Dapagliflozin
Product Origin
Generic Brand
Product Manufacturer
Healing Pharma India Pvt Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Pharmacological Class
SGLT2 Inhibitor
Manufacturer Description
Intended to relieve high blood sugar levels to support glycemic targets and target renal excretion pathways.
Mechanism of Action
Blocks SGLT2 in renal tubules, lowering renal glucose reabsorption threshold to promote glucose loss in urine.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe renal impairment (for glycemic control), Diabetic ketoacidosis
Severe Adverse Events
Diabetic ketoacidosis — requires immediate medical attention, Fournier's gangrene — requires immediate medical attention
Common Side Effects
Increased urination, Nausea
Uncommon Side Effects
Urinary tract infection, Vulvovaginal candidiasis, Dyslipidemia
Drug Interactions
Insulin, Diuretics
Pregnancy Safety Warnings
TGA Category C: Avoid in second and third trimesters. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 30°C.
Related Products
Information related to Dapasmart is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to order Hypertension Treatment - Buy Losartan AU